T. Rowe Price Health Sciences Fund (PRHSX)
Ticker Symbol:
PRHSX
Fund Status:
Open to new Retail investors  /  Open to subsequent Retail investments
Fund Composition
Asset Allocation
as of 03/31/2015
Domestic Stock 85.9%
Foreign Stock 8.6%
Cash 5.3%
Convertibles 0.4%
Foreign Bonds 0.0%
Preferreds 0.0%
Options -0.1%
Volatility and Other Measures
as of 03/31/2015
Beta 0.87
0.40
Standard Deviation 13.09
Price/Earnings Ratio (Domestic) 21.7
Earnings Growth Rate (Domestic) 13.2
Turnover Rate 9.3
Median Market
Capitalization
$29,994.6 Million
10 Largest Holdings
Represents 34.08 % of Total Net Assets
View Holdings as of:
Actavis plc
Aetna
Alexion Pharmaceuticals
Biogen
Gilead Sciences
Humana
McKesson
Pharmacyclics
UnitedHealth Group
Valeant Pharmaceuticals International
As of 03/31/2015 the Health Sciences Fund had a total of 157 holdings.
Sector Diversification
as of 03/31/2015
% of Total Net Assets
Biotechnology 31.7%
Services 25.5%
Pharmaceuticals 22.3%
Products & Devices 10.0%
Life Sciences 3.0%
Miscellaneous 2.4%
See Glossary for additional details on all data elements.